About the Cancer and Autoimmune Diseases Session
The connection between cancer and autoimmune diseases is complex, as some autoimmune conditions increase the risk of developing cancer, while certain cancer treatments can trigger autoimmune reactions. For example, individuals with rheumatoid arthritis, lupus, and other autoimmune diseases have a higher incidence of lymphoma and certain types of skin cancer. On the other hand, immunotherapies that stimulate the immune system to fight cancer can sometimes lead to autoimmune side effects, where the immune system attacks healthy tissues. Research in this area focuses on understanding the immune system’s role in both cancer progression and the development of autoimmune diseases, with the aim of finding safer and more effective treatment strategies that can balance the benefits of immune activation with the risk of autoimmune reactions.
Topics Covered in Cancer and Autoimmune Diseases
Lymphoma Risk
Chronic Inflammation
Immunosuppressant Risks
Immune-Related Toxicities
Pre-Existing Autoimmunity
Shared Immune Pathways
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer and Autoimmune Diseases Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer and Autoimmune Diseases work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer and Autoimmune Diseases research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer and Autoimmune Diseases track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer and Autoimmune Diseases Conference 2027 — FAQs
What is the Cancer and Autoimmune Diseases track at CIOC 2027?
The Cancer and Autoimmune Diseases track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer and Autoimmune Diseases. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer and Autoimmune Diseases sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer and Autoimmune Diseases are all welcome — whether presenting or attending.
Can I present my research in the Cancer and Autoimmune Diseases track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer and Autoimmune Diseases sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer and Autoimmune Diseases track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.